ResMed | RMD - Equity Capital And Reserves


ResMed reported $6.32B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Ansell USD 1.98B 72.5M Jun/2025
Artivion USD 438.69M 18.79M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Cochlear AUD 1.95B 82.7M Jun/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
CSL USD 21.41B 861M Jun/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Fisher Paykel Healthcare NZD 1.99B 95.8M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Philips EUR 10.58B 204M Sep/2025
Ramsay Health Care AUD 5.71B 894M Jun/2025
ResMed USD 6.32B 199.61M Dec/2025
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Steris USD 7.15B 145.4M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025